Finland – Antineoplastic and immunomodulating agents – CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2025 – 31.12.202
HUS-Yhtymä awarded a contract of undisclosed value to Novartis Finland Oy for Professional Services & Consulting in February 2025 — one of 1,479 awards this buyer has made.
Buying agency
HUS-YhtymäWinning supplier
Novartis Finland OyContract description
Finland – Antineoplastic and immunomodulating agents – CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2025 – 31.12.2025
Related awards · HUS-Yhtymä
1,479 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-500745-2024Renalis Oü€40.0M21 Aug 2024 Healthcare
- ocds-ted-206235-2024Gasum Oy€35.0M08 Apr 2024 Energy
- ocds-ted-432352-2026DHL Supply Chain (Finland) Oy€25.4M25 Jun 2026 Professional Services
Other wins · Novartis Finland Oy
5 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-65150-2025HUS-Yhtymä€8.0M30 Jan 2025 Healthcare
- ocds-ted-239917-2025HUS-Yhtymä€4.5M14 Apr 2025 Healthcare
- ocds-ted-62268-2026HUS-Yhtymä€2.0M28 Jan 2026 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for HUS-Yhtymä and Novartis Finland Oy — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back